Story perspectives
Psychedelics Activate Diverse Brain Pathways, Boosting Therapy Potential
9/2/2025
41 6
1 of 1
Story summary
- Research in Neuron shows classical psychedelics activate various brain receptors beyond the serotonin 5-HT2A receptor.
- The study analyzed 41 psychedelic compounds, highlighting potential benefits for depression and anxiety.
- Different psychedelics engage multiple signaling pathways, complicating the distinction between therapeutic and hallucinogenic effects.
- The dataset is a valuable resource for future psychedelic research and therapy development.
- The study calls for safer psychedelic-inspired molecules to reduce receptor activation risks.
